[go: up one dir, main page]

DK2001483T3 - Anvendelse af cholest-4-en-3-on-derivater til at opnå et cytoprotektivt lægemiddel - Google Patents

Anvendelse af cholest-4-en-3-on-derivater til at opnå et cytoprotektivt lægemiddel

Info

Publication number
DK2001483T3
DK2001483T3 DK07731211.4T DK07731211T DK2001483T3 DK 2001483 T3 DK2001483 T3 DK 2001483T3 DK 07731211 T DK07731211 T DK 07731211T DK 2001483 T3 DK2001483 T3 DK 2001483T3
Authority
DK
Denmark
Prior art keywords
gen
cholest
carbon
image
cytoprotective
Prior art date
Application number
DK07731211.4T
Other languages
English (en)
Inventor
Rebecca Pruss
Bruno Buisson
Thierry Bordet
Original Assignee
Trophos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos filed Critical Trophos
Application granted granted Critical
Publication of DK2001483T3 publication Critical patent/DK2001483T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK07731211.4T 2006-03-31 2007-03-28 Anvendelse af cholest-4-en-3-on-derivater til at opnå et cytoprotektivt lægemiddel DK2001483T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602799A FR2899108B1 (fr) 2006-03-31 2006-03-31 Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur
PCT/FR2007/000530 WO2007118967A1 (fr) 2006-03-31 2007-03-28 Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur

Publications (1)

Publication Number Publication Date
DK2001483T3 true DK2001483T3 (da) 2011-04-18

Family

ID=36954506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07731211.4T DK2001483T3 (da) 2006-03-31 2007-03-28 Anvendelse af cholest-4-en-3-on-derivater til at opnå et cytoprotektivt lægemiddel

Country Status (17)

Country Link
US (1) US9320745B2 (da)
EP (1) EP2001483B1 (da)
JP (2) JP5662020B2 (da)
KR (1) KR101409027B1 (da)
CN (1) CN101443019B (da)
AT (1) ATE493989T1 (da)
AU (1) AU2007239395B2 (da)
BR (1) BRPI0709925A8 (da)
CA (1) CA2647501C (da)
DE (1) DE602007011739D1 (da)
DK (1) DK2001483T3 (da)
ES (1) ES2359173T3 (da)
FR (1) FR2899108B1 (da)
IL (1) IL194293A0 (da)
MX (1) MX2008012611A (da)
RU (1) RU2428189C2 (da)
WO (1) WO2007118967A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
CA2704128A1 (fr) * 2007-10-30 2009-07-30 Trophos Nouvelle composition pour traiter les effets secondaires des traitements anticancereux
WO2012069150A2 (en) 2010-11-22 2012-05-31 Powerpore Gmbh Cytoprotectant agents for the prevention of drug-associated side-effects
FR2979239A1 (fr) 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
TWI648274B (zh) 2013-02-15 2019-01-21 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺類 （二）
RU2629772C1 (ru) * 2016-05-31 2017-09-04 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Кардиопротекторная фармацевтическая субстанция и способ ее получения
CN107746423B (zh) * 2017-09-07 2020-02-14 佛山科学技术学院 麦角甾-7，22-二烯-3-酮肟及其制备方法和在制备抗菌药物中的应用
CN115040524A (zh) * 2022-07-27 2022-09-13 深圳市中西医结合医院 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3186365B2 (ja) * 1993-09-02 2001-07-11 日本油脂株式会社 肝疾患治療薬
JP3129367B2 (ja) * 1993-10-08 2001-01-29 日本油脂株式会社 角化亢進抑制剤
JP4970932B2 (ja) * 2003-03-11 2012-07-11 トロフォ コレスト−４−エン−３−オンの誘導体の医薬としての使用、これらを含む医薬組成物、新規誘導体及びそれらの製造方法
EP1618881A1 (en) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
RU2008143248A (ru) 2010-05-10
MX2008012611A (es) 2008-10-31
CA2647501C (fr) 2013-10-08
HK1129841A1 (en) 2009-12-11
CN101443019A (zh) 2009-05-27
JP2009531397A (ja) 2009-09-03
EP2001483A1 (fr) 2008-12-17
FR2899108A1 (fr) 2007-10-05
WO2007118967A1 (fr) 2007-10-25
CA2647501A1 (fr) 2007-10-25
FR2899108B1 (fr) 2012-02-03
EP2001483B1 (fr) 2011-01-05
US20090186863A1 (en) 2009-07-23
BRPI0709925A2 (pt) 2011-08-02
CN101443019B (zh) 2013-07-17
AU2007239395B2 (en) 2012-05-24
IL194293A0 (en) 2009-09-22
US9320745B2 (en) 2016-04-26
DE602007011739D1 (de) 2011-02-17
BRPI0709925A8 (pt) 2018-04-24
JP2014051525A (ja) 2014-03-20
KR101409027B1 (ko) 2014-06-18
RU2428189C2 (ru) 2011-09-10
ATE493989T1 (de) 2011-01-15
ES2359173T3 (es) 2011-05-19
AU2007239395A1 (en) 2007-10-25
JP5662020B2 (ja) 2015-01-28
KR20090016549A (ko) 2009-02-16

Similar Documents

Publication Publication Date Title
DK2001483T3 (da) Anvendelse af cholest-4-en-3-on-derivater til at opnå et cytoprotektivt lægemiddel
WO2009005269A3 (en) Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives
EA201001595A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
ECSP034710A (es) Derivados biarilicos nicotinamida de utilidad como inhibidores de isozimas pde4
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
AR109357A2 (es) Composición farmacéutica parenteral con tolerancia en el sitio de inyección
AR062401A1 (es) Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis
UY30301A1 (es) Ácidos bifenilcarboxílicos substituidos y sus derivados
NO20052167L (no) Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe
UY27959A1 (es) Nuevos agonistas ppar alfa y ppar gama
WO2010132670A3 (en) Pentacycline compounds
MXPA03010867A (es) Nuevos derivados heterociclicos y uso farmaceutico de los mismos.
WO2009016081A3 (en) Benzoind0l-2-one derivatives for use in therapy
ATE511506T1 (de) Thiopen-derivate als wirkstoffe gegen okulare hypotonie
NZ590454A (en) Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology
MX362192B (es) Derivado de glicinamida alfa-sustituida.
ATE496903T1 (de) Thiophenderivate als medikamente zur behandlung von okularer hypertonie
AR026241A1 (es) Empleo de carbinoles 2-imidazolil substituidos para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas porestados isquemicos
DK1713543T3 (da) Anvendelse af substituerede indolizin-derivater til behandling af sygdomme, der er associeret med en patologisk angiogenese
NZ592930A (en) Arylcyclopropylacetamide derivatives useful as glucokinase activators
GB0600431D0 (en) Method
MX2025001438A (es) Compuesto heterociclico que contiene oxigeno y uso del mismo
GEAP202516640A (en) Crystal form of a pde4 inhibitor
ITMI20061305A1 (it) Forme cristalline di composti macrolidici dotati di attivita' antinfiammatoria